Heron Therapeutics, Inc. · NASDAQ:HRTX

Heron Therapeutics — Technical Presentation (2017)

8 slides from Heron Therapeutics's technical presentation, 2017

  1. Slide 1: HTX-011 Reduces Postoperative Pain and Opioid Consumption Following Abdominoplasty: Abstract

    HTX-011, a Proprietary, Unique, Long-Acting Local Anesthetic, Reduces Acute Postoperative Pain Intensity and Opioid Consumption Following Abdominoplasty David Leiman, MD;1 Harold S. Minkowitz, MD;1 Sanjay S. Patel, PhD;2 Guy Boccia;2 Alice Chu, MA;2 Linda Heiner;2 Mary Rose Keller;2 Erol Onel, MD;2

  2. Slide 2: Methods: Clinical Study Design

    HTX-011, a Proprietary, Unique, Long-Acting Local Anesthetic, Reduces Acute Postoperative Pain Intensity and Opioid Consumption Following Abdominoplasty David Leiman, MD;1 Harold S. Minkowitz, MD;1 Sanjay S. Patel, PhD;2 Guy Boccia;2 Alice Chu, MA;2 Linda Heiner;2 Mary Rose Keller;2 Erol Onel, MD;2

  3. Slide 3: Baseline Population Characteristics

    HTX-011, a Proprietary, Unique, Long-Acting Local Anesthetic, Reduces Acute Postoperative Pain Intensity and Opioid Consumption Following Abdominoplasty David Leiman, MD;1 Harold S. Minkowitz, MD;1 Sanjay S. Patel, PhD;2 Guy Boccia;2 Alice Chu, MA;2 Linda Heiner;2 Mary Rose Keller;2 Erol Onel, MD;2

  4. Slide 4: Efficacy – Pain Reduction

    HTX-011, a Proprietary, Unique, Long-Acting Local Anesthetic, Reduces Acute Postoperative Pain Intensity and Opioid Consumption Following Abdominoplasty David Leiman, MD;1 Harold S. Minkowitz, MD;1 Sanjay S. Patel, PhD;2 Guy Boccia;2 Alice Chu, MA;2 Linda Heiner;2 Mary Rose Keller;2 Erol Onel, MD;2

  5. Slide 5: Efficacy – Postoperative Opioid Rescue Medication Use

    HTX-011, a Proprietary, Unique, Long-Acting Local Anesthetic, Reduces Acute Postoperative Pain Intensity and Opioid Consumption Following Abdominoplasty David Leiman, MD;1 Harold S. Minkowitz, MD;1 Sanjay S. Patel, PhD;2 Guy Boccia;2 Alice Chu, MA;2 Linda Heiner;2 Mary Rose Keller;2 Erol Onel, MD;2

  6. Slide 6: Safety

    HTX-011, a Proprietary, Unique, Long-Acting Local Anesthetic, Reduces Acute Postoperative Pain Intensity and Opioid Consumption Following Abdominoplasty David Leiman, MD;1 Harold S. Minkowitz, MD;1 Sanjay S. Patel, PhD;2 Guy Boccia;2 Alice Chu, MA;2 Linda Heiner;2 Mary Rose Keller;2 Erol Onel, MD;2

  7. Slide 7: Conclusions

    HTX-011, a Proprietary, Unique, Long-Acting Local Anesthetic, Reduces Acute Postoperative Pain Intensity and Opioid Consumption Following Abdominoplasty David Leiman, MD;1 Harold S. Minkowitz, MD;1 Sanjay S. Patel, PhD;2 Guy Boccia;2 Alice Chu, MA;2 Linda Heiner;2 Mary Rose Keller;2 Erol Onel, MD;2

  8. Slide 8: References

    HTX-011, a Proprietary, Unique, Long-Acting Local Anesthetic, Reduces Acute Postoperative Pain Intensity and Opioid Consumption Following Abdominoplasty David Leiman, MD;1 Harold S. Minkowitz, MD;1 Sanjay S. Patel, PhD;2 Guy Boccia;2 Alice Chu, MA;2 Linda Heiner;2 Mary Rose Keller;2 Erol Onel, MD;2

Heron Therapeutics — Technical Presentation (2017) on 6ix